Anacor discovers, develops and commercializes novel small-molecule therapeutics for the treatment of fungal, bacterial and inflammatory diseases.
Business Model:
Revenue: $84.6M
Employees: 51-200
Address: 1020 E Meadow Cir
City: Palo Alto
State: CA
Zip: 94303
Country: US
Anacor discovers, develops and commercializes novel small-molecule therapeutics for the treatment of fungal, bacterial and inflammatory diseases.
Contact Phone:
+16505437500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/24/2010
Ticker Symbol:
ANAC
IPO Price:
$5/share
Amount Raised:
$60M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|